E Fund Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $625K | Buy |
18,919
+5,136
| +37% | +$170K | 0.03% | 204 |
|
|
2025
Q1 | $554K | Buy |
13,783
+2,039
| +17% | +$81.9K | 0.03% | 213 |
|
|
2024
Q4 | $552K | Sell |
11,744
-1,993
| -15% | -$93.8K | 0.03% | 214 |
|
|
2024
Q3 | $725K | Sell |
13,737
-2,190
| -14% | -$116K | 0.04% | 166 |
|
|
2024
Q2 | $863K | Buy |
15,927
+9,336
| +142% | +$506K | 0.05% | 137 |
|
|
2024
Q1 | $462K | Sell |
6,591
-7,494
| -53% | -$525K | 0.03% | 166 |
|
|
2023
Q4 | $1.18M | Buy |
14,085
+1,404
| +11% | +$117K | 0.07% | 81 |
|
|
2023
Q3 | $374K | Buy |
12,681
+619
| +5% | +$18.3K | 0.03% | 177 |
|
|
2023
Q2 | $393K | Buy |
12,062
+1,214
| +11% | +$39.6K | 0.03% | 176 |
|
|
2023
Q1 | $382K | Sell |
10,848
-958
| -8% | -$33.7K | 0.03% | 181 |
|
|
2022
Q4 | $541K | Buy |
11,806
+3,068
| +35% | +$141K | 0.05% | 123 |
|
|
2022
Q3 | $423K | Sell |
8,738
-2,348
| -21% | -$114K | 0.04% | 167 |
|
|
2022
Q2 | $436K | Buy |
11,086
+3,932
| +55% | +$155K | 0.04% | 172 |
|
|
2022
Q1 | $263K | Buy |
7,154
+2,350
| +49% | +$86.4K | 0.01% | 243 |
|
|
2021
Q4 | $219K | Sell |
4,804
-1,036
| -18% | -$47.2K | 0.01% | 244 |
|
|
2021
Q3 | $209K | Buy |
+5,840
| New | +$209K | 0.01% | 227 |
|